1. D. C. Washington, Availability of Radioactive Isotopes: Announcement from Headquarters, Manhattan Project, Journal of Science and Technology, 103(2685), 71 (1946).
2. (IAEA) International Atomic Energy Agency, Charged particle cross-section database for medical radioisotope production: diagnostic radioisotopes and monitor reactions, No. 1011–4289, Vienna, 4, (2001).
3. V. R. Narra, R. W. Howell, R. S. Harapanhalli, K. S. Sastry and D. V. Rao, Radiotoxicity of some Iodine-123, Iodine-125, and Iodine- 131-labeled compounds in mouse testes: Implications for radiopharmaceutical design, Journal of Nuclear Medicine, 33(12), 2196 (1992).
4. E. Rault, Comparison of Image Quality of Different Iodine Isotopes (I-123, I-124 and I-131), Journal of Cancer Biotherapy and Radiopharmaceuticals, 22(3), 423–430 (2007).
5. R. M. Lambrecht and A. P. Wolf, 'Cyclotron and Short-Lived Halogen Isotopes for Radiopharmaceutical Applications. In New Developments in Radiopharmaceuticals and Labelled Compounds, (IAEA) Vienna, 1, 275-290 (1973).